- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04700540
A Mobile Informatics Solution to Aid in Memory
March 4, 2025 updated by: University of Minnesota
The researchers propose to develop an informatics system to assist people with memory impairment.
Persons with Memory Concern (PWMC) recognize the faces they see daily, such as a spouse or caregiver, but they may confuse visiting friends and grandchildren or they may not match names with faces well.
The inability to remember names or relationships contributes to isolation and deeply affects their social lives.
The proposed solution is a Smartwatch Reminder (SR) system to conspicuously provide this information to the PWMC when needed.
The system will be evaluated on the target persons with memory concern population to measure engagement and improvements in social interactions and quality of life.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This research will evaluate technology designed to improve the quality of life for persons with dementia through external aids to assist with remembering.
The primary goal of the Smartwatch Reminder (SR) is to facilitate social interaction for Persons with Memory Concern (PWMC) by providing facial recognition of family, friends, and other key people.
The SR will be evaluated using an embedded experimental mixed methods design that combines the collection and analysis of qualitative data within a traditional randomized controlled trial design.
To do so, researchers will enroll 100 PWMC and their care partners to participate in initial, 3-month, and 6-month surveys.
Half of the PWMCs will be randomly assigned to the intervention group (i.e.
receive the SR) and the other half randomly assigned to the attention control group.
Each participant will take part in the study for a total of 6 months.
All study procedures and data analysis are anticipated to be completed within 24 months.
Study Type
Interventional
Enrollment (Actual)
162
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- University of Minnesota
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion criteria for PWMC are as follows:
- English speaking
- a physician diagnosis of early-stage Alzheimer's disease or mild-to-moderate cognitive impairment
- no history of serious mental illness (i.e., any major psychiatric disorder)
Inclusion criteria for care partners of PWMC are as follows:
- English speaking
- 21 years of age or over
- self-identifies as someone who provides assistance to the PWMC because of their memory loss (these individuals are called ''care partners,'' as these individuals may or may not provide the intensive hands-on care typical of ''caregivers'')
- plans to remain in the area for at least 6 months in order to reduce loss to follow-up
- indicates a willingness to use the smartwatch system
Exclusion Criteria for PWMC are as follows:
- non-English speaking
- no physician diagnosis of early-stage Alzheimer's disease or mild-to-moderate cognitive impairment
- a history of serious mental illness (i.e., any major psychiatric disorder)
Exclusion criteria for care partners of PWMC are as follows:
- non-English speaking
- under 21 years of age
- does not identify as someone who provides assistance to the PWMC because of their memory loss
- does not plan on remaining in the area for at least 6 months
- does not indicate a willingness to use the smartwatch system
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Group
The PWMC and Care partner in this group will receive the SR.
The project will provide a smartwatch and smartphone for the dyads in the study.
All others (family, friends, etc.) will be able to download a smartphone app from an online store.
Instructional material will be created to show the suggested information that can be entered into the app.
Care partners and PWMC are administered surveys at baseline and 3 months following enrollment.
|
The Smartwatch Reminder (SR) system will automatically transmit pictures and relevant information, such as name or relationship, to a smartwatch worn by the PWMC when family or friends visit.
|
|
No Intervention: Attention Control Group
Care partners are administered surveys at baseline and 3 months following enrollment.
The attention control group will receive a contact call from one of the researchers 3-months after enrollment.
Based on our prior experience, PWMC and care partners in an attention control group will often seek information and psychosocial support during these calls.
We will provide free information resources (e.g., brochures or websites of the Alzheimer's Association) at that time.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PWMC Loneliness
Time Frame: 3 months
|
Original three-item measure, including:
|
3 months
|
|
PWMC Social Relationships and Social Support
Time Frame: 3 months
|
The Lubben Social Network Scale (LSNS) is a measure of social relationships and social support networks.
We used the shortened 6-item scale to reduce test burden.
The 6-item scale has a range of 0 - 30 with higher scores indicating more robust social networks / access to support.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PWMC Physical and Mental Well-being
Time Frame: 3 months
|
We used the Global Health Scale.
This tool is designed to assess an individual's overall physical and mental wellbeing.
The scale measures subjective health perceptions.
Scale scores range from 0 - 100, with higher scores indicating higher rates of mental and physical well-being.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2022
Primary Completion (Actual)
April 1, 2024
Study Completion (Actual)
April 1, 2024
Study Registration Dates
First Submitted
December 17, 2020
First Submitted That Met QC Criteria
January 6, 2021
First Posted (Actual)
January 8, 2021
Study Record Updates
Last Update Posted (Estimated)
March 26, 2025
Last Update Submitted That Met QC Criteria
March 4, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SPH-2023-31117
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Public access to the research data generated from this project will be offered via de-identified data files maintained by the investigators.
All personal identifiers of family caregivers of persons with Alzheimer's disease or a related dementia (ADRD) participating in the study will be removed and replaced with random identification numbers prior to distributing data files.
Potential external investigators will be asked to complete a data use agreement and a recommended citation to these materials will be provided.
Data from the project will be maintained on a secure University of Minnesota School of Public Health shared server for 3 years following study completion.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
Benjamin Rose Institute on AgingNational Institute on Aging (NIA)RecruitingMild Dementia | Moderate DementiaUnited States
-
Yaolin PeiNational Institutes of Health (NIH)RecruitingEnd of Life Decision Making | Dementia Caregivers | Advanced DementiaUnited States
-
Benuvia Therapeutics Inc.MandaraNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityCompletedDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeActive, not recruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
The University of Hong KongNot yet recruiting
-
Temple UniversityCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
Clinical Trials on Smartwatch Reminder (SR) system
-
University of RostockGerman Center for Neurodegenerative Diseases (DZNE); Fraunhofer InstituteCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia FrontotemporalGermany
-
HabitAware Inc.University of MinnesotaNot yet recruitingBinge-Eating Disorder
-
Philips Electronics Nederland B.V. acting through...UMC UtrechtCompleted
-
University of AlbertaAlberta Health servicesCompletedKnowledge Translation | Sustainability of InnovationsCanada
-
University of Sao PauloSamsung Eletrônica da Amazônia LtdaRecruitingHeart Diseases | Angina, Unstable | Atrial Fibrillation (AF)Brazil
-
Fundación para la Investigación del Hospital Clínico...RecruitingQuality of Life | Pain | Breast Cancer | Physical Activity | Stress | Sleep QualitySpain
-
Mahsa UniversityCompleted
-
AVAVA, Inc.Completed
-
Planned Parenthood Federation of AmericaMerck Sharp & Dohme LLCCompletedGARDASIL VaccinationUnited States